Africa

Vaccine
#Africa #University of Oxford #Vaccines

Oxford’s Lassa fever vaccine administered in trial 

The first volunteer has been dosed in a first-in-human trial of the Lassa vaccine, marking an unprecedented step towards treating Lassa fever.  The vaccine, developed by the University of Oxford, is being assessed for its safety and the immune response it triggers in volunteers. Thirty-one people aged… Read More

#News

Vaccine
#Africa #HIV #Phase I trial #Vaccines

Partners launch trial of novel HIV vaccine in Africa

A Phase I clinical trial of a novel T cell-inducing HIV vaccine candidate has launched in Africa to evaluate immune responses to highly networked HIV T-cell epitopes.  The trial is a collaboration between The Mutala Trust, ReiThera Srl (ReiThera), the Ragon Institute of Mass General Brigham, MIT,… Read More

#News

Genetics
#Africa #Childhood cancer #Nanopore sequencing #Oncology #Oxford Nanopore Technologies #Paediatrics

Consortium hopes to improve childhood cancer survival in Africa

Oxford Nanopore Technologies has joined the PROGRESS study to support improved outcomes for childhood leukaemias in Ghana. The consortium so far includes Yemaachi Biotech, Pediatric Oncology Units at Korle Bu Teaching Hospital, Komfo Anokye Teaching Hospital and Greater Accra Regional Hospital, and institutions like Newcastle University,… Read More

#Cancer Research #News

MRI of the brain
#Africa #Collaboration #epilepsy #LMICs #University of Oxford

Oxford centre to address global epilepsy challenges

The University of Oxford is launching The Centre for Global Epilepsy to address the global burden of epilepsy, particularly in lower-income countries. Based at Wolfson College, Oxford, the Centre for Global Epilepsy will collaborate with key research institutions and epilepsy clinics worldwide, linking expertise from high-income… Read More

#News

Child receiving treatment for malaria
#Africa #Clinical trial #Malaria #Monoclonal antibodies #Therapeutic Antibodies

Experimental malaria monoclonal antibody prevents infection

A single injection of an experimental monoclonal antibody called L9LS was 77% effective at preventing malaria infection in children in Mali, according to the results of a mid-stage clinical trial. L9LS binds to and neutralises ‘sporozoites’, the form of the malaria parasite transmitted by mosquitoes that… Read More

#News #Trending News

Genomic profiling
#Africa #Antibiotic resistance #Antimicrobial resistance (AMR) #Genetics / genomics #Immunology / Virology & Vaccines

Scientists use genomics to counter antimicrobial resistant typhoid

Genome sequencing has been used to study typhoid fever in a study in Zimbabwe and understand how the disease has evolved to be resistant to treatment. Typhoid fever claims over 135,000 lives annually. Treating it relies on antimicrobials but in the last couple of decades, antimicrobial… Read More

#News

Malaria vaccine
#Africa #Immunology / Virology & Vaccines #Malaria #Regulatory #Serum Institute of India #University of Oxford #Vaccines

Ghana vaccine approval a ‘critical step’ in combatting malaria

The R21/Matrix-M malaria vaccine has received regulatory clearance for use in Ghana by the country’s Food and Drugs Authority, making it the first country to approve the vaccine. R21/Matrix-M was developed by the University of Oxford and manufactured and scaled up by the Serum Institute of India (SIIPL), leveraging Novavax’s… Read More

#News #Regulatory #Trending News

African medical researchers
#Africa #AI / data analytics / healthtech / informatics #Collaboration #Collaborative Drug Discovery (CDD) #Data management #Drug discovery

Informatics resource advances drug discovery in Africa

African researchers are now able to access Collaborative Drug Discovery’s CDD Vault resource for neglected disease drug discovery collaborations.  Collaborative Drug Discovery (CDD), a scientific informatics company that provides data management and analysis solutions, is offering free subscriptions to CDD Vault for select academic teams of scientists… Read More

#News